Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate cancer cells

Journal of Biological Chemistry

Volumn 287, Issue 22, 2012, Pages 18287-18296

  Guturi, Kiran Kumar Naidu ^a   Mandal, Tapashi ^a   Chatterjee, Anirban ^a   Sarkar, Moumita ^a   Bhattacharya, Seemana ^a   Chatterjee, Uttara ^b   Ghosh, Mrinal K ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DEVELOPMENT; CHROMATIN IMMUNOPRECIPITATION; EPIDERMAL GROWTH FACTOR RECEPTORS; GLYCOGEN SYNTHASE KINASE-3; HUMAN CANCER; MULTIPLE GENES; PROMOTER ANALYSIS; PROSTATE CANCER CELLS; PROTEIN KINASE A; TARGET GENES; TRANSCRIPTIONAL REGULATION; TRANSCRIPTIONALLY ACTIVE; UP-REGULATION;

CELL PROLIFERATION; CELLS; DISEASES; GENE EXPRESSION; PHOSPHORYLATION;

GENE EXPRESSION REGULATION;

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; BETA CATENIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; SERINE; STAT3 PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOACCUMULATION; CANCER CELL; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; ENZYME INACTIVATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; TRANSCRIPTION REGULATION; UPREGULATION;

BETA CATENIN; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MICROSCOPY, FLUORESCENCE; PROSTATIC NEOPLASMS; RECEPTOR CROSS-TALK; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANSCRIPTION, GENETIC;

EID: 84861553906     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.324798     Document Type: Article

References (52)

1. Ozawa, M., Baribault, H., and Kemler, R. (1989) The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 8, 1711-1717 (Pubitemid 19273986)
2. Huber, A. H., and Weis, W. I. (2001) The structure of the β-catenin/Ecadherin complex and the molecular basis of diverse ligand recognition by β-catenin. Cell 105, 391-402 (Pubitemid 32455345)
3. Huelsken, J., and Behrens, J. (2002) The Wnt signaling pathway. J. Cell Sci. 115, 3977-3978
4. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., Kinzler, K. W. (1997) Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790 (Pubitemid 27136715)
5. Voeller, H. J., Truica, C. I., and Gelmann, E. P. (1998) β-Catenin mutations in human prostate cancer. Cancer Res. 58, 2520-2523 (Pubitemid 28275418)
6. Gerstein, A. V., Almeida, T. A., Zhao, G., Chess, E., Shih, I. e. M., Buhler, K., Pienta, K., Rubin, M. A., Vessella, R., and Papadopoulos, N. (2002) APC/CTNNB1 (β-catenin) pathway alterations in human prostate cancers. Genes Chromosomes Cancer 34, 9-16 (Pubitemid 34260591)
7. Chesire, D. R., Ewing, C. M., Sauvageot, J., Bova, G. S., and Isaacs, W. B. (2000) Detection and analysis of β-catenin mutations in prostate cancer. Prostate 45, 323-334
8. Daugherty, R. L., and Gottardi, C. J. (2007) Phosphoregulation of β-catenin adhesion and signaling functions. Physiology 22, 303-309
9. Fang, D., Hawke, D., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G. B., Kobayashi, R., Hunter, T., and Lu, Z. (2007) Phosphorylation of β-catenin by AKT promotes β-catenin transcriptional activity. J. Biol. Chem. 282, 11221-11229 (Pubitemid 47100795)
10. Taurin, S., Sandbo, N., Qin, Y., Browning, D., Dulin, N. O. (2006) Phosphorylation of β-catenin by cyclic AMP-dependent protein kinase. J. Biol. Chem. 281, 9971-9976 (Pubitemid 43864529)
11. Verheyen, E. M., and Gottardi, C. J. (2010) Regulation of Wnt/β-catenin signaling by protein kinases. Dev. Dyn. 239, 34-44
12. 552. Biochem. Biophys. Res. Commun. 395, 146-151
13. Chesire, D. R., and Isaacs, W. B. (2002) Ligand-dependent inhibition of β-catenin/TCF signaling by androgen receptor. Oncogene 21, 8453-8469 (Pubitemid 36054886)
14. Bierie, B., Nozawa, M., Renou, J. P., Shillingford, J. M., Morgan, F., Oka, T., Taketo, M. M., Cardiff, R. D., Miyoshi, K., Wagner, K. U., Robinson, G. W., and Hennighausen, L. (2003) Activation of β-catenin in prostate epithelium induces hyperplasias and squamous transdifferentiation. Oncogene 22, 3875-3887 (Pubitemid 36819661)
15. Gullick, W. J. (1991) Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br. Med. Bull. 47, 87-98
16. Di Lorenzo, G., Tortora, G., D'Armiento, F. P., De Rosa, G., Staibano, S., Autorino, R., D'Armiento, M., De Laurentiis, M., De Placido, S., Catalano, G., Bianco, A. R., and Ciardiello, F. (2002) Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen independence in human prostate cancer. Clin. Cancer Res. 8, 3438-3444 (Pubitemid 35340719)
17. Di Fiore, P. P., Pierce, J. H., Fleming, T. P., Hazan, R., Ullrich, A., King, C. R., Schlessinger, J., and Aaronson, S. A. (1987) Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH-3T3 cells. Cell 51, 1063-1070
18. Di Fiore, P. P., Pierce, J. H., Kraus, M. H., Segatto, O., and King, C. R., and Aaronson, S. A. (1987) erbB-2 is a potent oncogene when overexpressed in NIH-3T3 cells. Science 237, 178-182 (Pubitemid 17095921)
19. Djakiew, D. (2000) Dysregulated expression of growth factors and their receptors in the development of prostate cancer. Prostate 42, 150-160
20. Connolly, J. M., and Rose, D. P. (1991) Autocrine regulation of DU145 human prostate cancer cell growth by epidermal growth factor-related polypeptides. Prostate 19, 173-180
21. Shah, R. B., Ghosh, D., and Elder, J. T. (2006) Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: Correlation with androgen independence. Prostate 66, 1437-1444 (Pubitemid 44350369)
22. Ghosh, M. K., Sharma, P., Harbor, P. C., Rahaman, S. O., and Haque, S. J. (2005) PI3K-AKT pathway negatively controls EGFR-dependent DNAbinding activity of Stat3 in glioblastoma multiforme cells. Oncogene 24, 7290-7300 (Pubitemid 41622233)
23. Ghosh, M. K., and Harter, M. L. (2003) A viral mechanism for remodeling chromatin structure in G0 cells. Mol. Cell 12, 255-260 (Pubitemid 36945049)
24. Sha, J., Ghosh, M. K., Zhang, K., and Harter, M. L. (2010) E1A interacts with two opposing transcriptional pathways to induce quiescent cells into S phase. J. Virol. 84, 4050-4059
25. Sarbassov, D. D., and Sabatini, D. M. (2005) Redox regulation of the nutrient-sensitive raptor-mTOR pathway and complex. J. Biol. Chem. 280, 39505-39509 (Pubitemid 41713908)
26. Festuccia, C., Muzi, P., Millimaggi, D., Biordi, L., Gravina, G. L., Speca, S., Angelucci, A., Dolo, V., Vicentini, C., and Bologna, M. (2005) Molecular aspects of gefitinib antiproliferative and proapoptotic effects in PTENpositive and PTEN-negative prostate cancer cell lines. Endocr. Relat. Cancer 12, 983-998 (Pubitemid 41815791)
27. O'Brien, W. T., and Klein, P. S. (2009) Validating GSK3 as an in vivo target of lithium action. Biochem. Soc. Trans. 37, 1133-1138
28. Mishra, R. (2010) Glycogen synthase kinase 3β: Can it be a target for oral cancer. Mol. cancer 9, 144
29. Jaggi, M., Johansson, S. L., Baker, J. J., Smith, L. M., Galich, A., and Balaji, K. (2005) Aberrant expression of E-cadherin and β-catenin in human prostate cancer. Urol. Oncol. 23, 402-406 (Pubitemid 41654506)
30. Whitaker, H. C., Girling, J., Warren, A. Y., Leung, H., Mills, I. G., and Neal, D. E. (2008) Alterations in β-catenin expression and localization in prostate cancer. The Prostate 68, 1196-1205
31. Schlomm, T., Kirstein, P., Iwers, L., Daniel, B., Steuber, T., Walz, J., Chun, F. H., Haese, A., Kollermann, J., Graefen, M., Huland, H., Sauter, G., Simon, R., and Erbersdobler, A. (2007) Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer. Clin. Cancer Res. 13, 6579-6584 (Pubitemid 350206791)
32. Moore, M. J., Kanter, J. R, Jones, K. C., and Taylor, S. S. (2002) Phosphorylation of the catalytic subunit of protein kinase A. Autophosphorylation versus phosphorylation by phosphoinositide-dependent kinase-1. J. Biol. Chem. 277, 47878-47884 (Pubitemid 36159315)
33. Li, Q., Dashwood, W. M., Zhong, X., Al-Fageeh, M., and Dashwood, R. H. (2004) Cloning of the rat β-catenin gene (Ctnnb1) promoter and its functional analysis compared with the Catnb and CTNNB1 promoters. Genomics 83, 231-242 (Pubitemid 38050112)
34. Bandapalli, O. R., Dihlmann, S., Helwa, R., Macher-Goeppinger, S., Weitz, J., Schirmacher, P., and Brand, K. (2009) Transcriptional activation of the β-catenin gene at the invasion front of colorectal liver metastases. J. Pathol. 218, 370-379
35. Yu, H., and Jove, R. (2004) The STATs of cancer-new molecular targets come of age. Nat. Rev. Cancer 4, 97-105 (Pubitemid 38198738)
36. Wang, Q., Zhou, Y., Wang, X., and Evers, B. M. (2006) Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase. Oncogene 25, 43-50 (Pubitemid 43050002)
37. Xu, C., Kim, N. G., and Gumbiner, B. M. (2009) Regulation of protein stability by GSK3 mediated phosphorylation. Cell Cycle 8, 4032-4039
38. Beurel, E., and Jope, R. S. (2006) The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog. Neurobiol. 79, 173-189 (Pubitemid 44331500)
39. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., and Thun, M. J. (2008) Cancer statistics, 2008. CA. Cancer J. Clin. 58, 71-96 (Pubitemid 351521864)
40. Lu, Z., and Hunter, T. (2004) Wnt-independent β-catenin transactivation in tumor development. Cell Cycle 3, 571-573 (Pubitemid 40278191)
41. Yardy, G. W., and Brewster, S. F. (2005) Wnt signaling and prostate cancer. Prostate Cancer Prostatic Dis. 8, 119-126
42. Das, T., Sa, G., Saha, B., and Das, K. (2010) Multifocal signal modulation therapy of cancer: Ancient weapon, modern targets. Mol. Cell Biochem. 336, 85-95
43. Luwor, R., Taylor, L., Wang, B., and Zhu, H. J. (January 23, 2008) Tumor-associated EGFR overexpression specifically activates Stat3 and Smad7 resulting in desensitization of TGF-β signaling. Nature Precedings, hdl:10101/npre.2008.1535.1
44. Lorenzo, G. D., Bianco, R., Tortora, G., and Ciardiello, F. (2003) Involvement of growth factor receptors of the epidermal growth factor receptor family in prostate cancer development and progression to androgen independence. Clin. Prostate Cancer 2, 50-57 (Pubitemid 37012422)
45. He, X. C., Yin, T., Grindley, J. C., Tian, Q., Sato, T., Tao, W. A., Dirisina, R., Porter-Westpfahl, K. S., Hembree, M., Johnson, T., Wiedemann, L. M., Barrett, T. A., Hood, L., Wu, H., and Li, L. (2007) PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat. Genet. 39, 189-198 (Pubitemid 46184349)
46. Tan, X., Apte, U., Micsenyi, A., Kotsagrelos, E., Luo, J. H., Ranganathan, S., Monga, D. K., Bell, A., Michalopoulos, G. K., and Monga, S. P. (2005) Epidermal growth factor receptor: A novel target of the Wnt/β-catenin pathway in liver. Gastroenterology 129, 285-302 (Pubitemid 41002061)
47. Hatzis, P., van der Flier, L. G., van Driel, M. A., Guryev, V., Nielsen, F., Denissov, S., Nijman, I. J., Koster, J., Santo, E. E., Welboren, W., Versteeg, R., Cuppen, E., van de Wetering, M., Clevers, H., and Stunnenberg, H. G. (2008) Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol. Cell Biol. 28, 2732-2744 (Pubitemid 351542371)
48. Bottomly, D., Kyler, S. L., McWeeney, S. K., and Yochum, G. S. (2010) Identification of β-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res. 38, 5735-5745
49. Hu, T., and Li, C. (2010) Convergence between Wnt-β-catenin and EGFR signaling in cancer. Mol. Cancer 9, 236
50. Musgrove, E. A. (2004) Wnt signaling via the epidermal growth factor receptor: A role in breast cancer? Breast Cancer Res. 6, 65-88
51. Siddique, H. R., Mishra, S. K., Karnes, R. J., and Saleem, M. (2011) Lupeol, a novel androgen receptor inhibitor: Implications in prostate cancer therapy. Clin. Cancer Res. 17, 5379-5391
52. Saia, G., Zhang, M., Depalo, V., Lautenschlager, T., and Chakravarti, A. (2007) Molecular and genetic profiling of prostate cancer: Implications for future therapy. Curr. Cancer Ther. Rev. 3, 25-36 (Pubitemid 46510731)